- $171.69m
- $43.21m
- $315.66m
- 45
- 63
- 78
- 65
Annual cashflow statement for Inogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 20.9 | -5.83 | -6.33 | -83.8 | -102 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 30.8 | 24.4 | 14 | 67.4 | 67 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -27.9 | -0.031 | -20.1 | -44.7 | 14.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 40.6 | 37 | 23.6 | -37.5 | -3.23 |
| Capital Expenditures | -3.4 | -17.6 | -24.1 | -21.2 | -27 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -40.7 | -8.04 | 9.42 | 10.3 | -32.3 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -44.1 | -25.6 | -14.6 | -10.9 | -59.3 |
| Financing Cash Flow Items | 1.82 | 1.73 | 1.3 | 0.336 | 0.576 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 4.93 | 2.07 | 15 | 0.38 | 0.96 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.4 | 13.9 | 23.6 | -48.5 | -61.5 |